Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of VCAN mRNA | increases expression | 19933214
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of VCAN protein | affects expression | 20106945
|
D016589 |
Astemizole |
Astemizole results in decreased expression of VCAN mRNA | decreases expression | 20221588
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene affects the expression of VCAN mRNA | affects expression | 20106945
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of VCAN mRNA | decreases expression | 15336504
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of VCAN mRNA | affects expression | 12734012
|
D003345 |
Corticosterone |
Corticosterone results in decreased expression of VCAN mRNA | decreases expression | 15755911
|
D003474 |
Curcumin |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VCAN mRNA] | decreases reaction|increases expression | 18200517
|
D003907 |
Dexamethasone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of VCAN mRNA | affects cotreatment|increases expression | 16054899
|
D005047 |
Etoposide |
VCAN protein affects the susceptibility to Etoposide | affects response to substance | 16217747
|
D006820 |
Hyaluronic Acid |
VCAN protein binds to and results in increased stability of Hyaluronic Acid | affects binding|increases stability | 15836955
|
D015056 |
1-Methyl-3-isobutylxanthine |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of VCAN mRNA | affects cotreatment|increases expression | 16054899
|
C000873 |
methylprednisolone acetate |
methylprednisolone acetate results in decreased expression of VCAN mRNA | decreases expression | 15693093
|
D008942 |
Mitoxantrone |
VCAN protein affects the susceptibility to Mitoxantrone | affects response to substance | 16217747
|
D010656 |
Phenylephrine |
Phenylephrine results in increased expression of VCAN mRNA | increases expression | 18158353
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of VCAN mRNA | affects binding|decreases expression|increases activity | 19710929
|
C116926 |
rofecoxib |
rofecoxib results in decreased expression of VCAN mRNA | decreases expression | 17070997
|
C089730 |
rosiglitazone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of VCAN mRNA | affects cotreatment|increases expression | 16054899
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of VCAN mRNA | increases expression | 20308225
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of VCAN mRNA | decreases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin affects the expression of VCAN mRNA | affects expression | 18691609
|
D019772 |
Topotecan |
VCAN protein affects the susceptibility to Topotecan | affects response to substance | 16217747
|
D014302 |
Trinitrobenzenesulfonic Acid |
Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VCAN mRNA] | decreases reaction|increases expression | 18200517
|
D014302 |
Trinitrobenzenesulfonic Acid |
Trinitrobenzenesulfonic Acid results in increased expression of VCAN mRNA | increases expression | 18200517
|
D014415 |
Tunicamycin |
Tunicamycin results in decreased expression of VCAN mRNA | decreases expression | 17127020
|
D014415 |
Tunicamycin |
Tunicamycin results in increased expression of VCAN mRNA | increases expression | 17127020
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.70 | 14514962 15322242 11752688 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.97 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
1.95 | 20464547 20127859 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.57 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.39 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.39 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.55 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.75 | 17306315 16712894 |
MESH:D019973 |
Alcohol-Related Disorders |
|
Curcumin |
4.93 | 17887948 |
MESH:D000544 |
Alzheimer Disease |
|
Curcumin |
4.44 | 15590663 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
4.44 | 19621015 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.81 | 11748828 |
MESH:D000799 |
Angioedema |
|
Astemizole |
5.51 | 2883202 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.92 | 19183758 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
3.98 | 17460149 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
7.69 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
rofecoxib |
7.69 | 16690336 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Curcumin |
2.70 | 16807698 |
MESH:D050197 |
Atherosclerosis |
|
Curcumin |
3.23 | 18704882 |
MESH:D001327 |
Autoimmune Diseases |
|
Curcumin |
4.34 | 19761891 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.31 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.31 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.64 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.67 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Etoposide |
5.01 | 14601052 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.39 | 15306635 |
MESH:D002545 |
Brain Ischemia |
|
Curcumin |
4.18 | 16770732 |
MESH:D001932 |
Brain Neoplasms |
|
Curcumin |
3.80 | 17596214 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.96 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Curcumin |
1.96 | 18462866 19250217 18593918 16243823 |
MESH:D001943 |
Breast Neoplasms |
|
Etoposide |
1.96 | 16322251 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.96 | 20435547 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.63 | 16124888 15673190 16097048 15721981 10355542 16192424 3786805 16050911 18705752 15700767 16011737 16227642 |
MESH:D002277 |
Carcinoma |
|
Curcumin |
7.88 | 18593918 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.88 | 16835633 |
MESH:D003528 |
Carcinoma, Adenoid Cystic |
marker/mechanism |
|
| 16762588 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
4.49 | 21507988 12907637 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
4.49 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
4.49 | 17306315 15276417 16507464 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Curcumin |
2.93 | 18414057 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
7.31 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Curcumin |
7.31 | 18462866 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.31 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
6.60 | 16170337 17124262 11754973 17287366 11179087 15728586 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.60 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
2.89 | 19524636 20056578 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.03 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.71 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.04 | 16354765 12621046 15668235 15340226 8697196 |
MESH:D003092 |
Colitis |
|
Curcumin |
9.45 | 16804969 18200517 16782535 |
MESH:D003092 |
Colitis |
|
Trinitrobenzenesulfonic Acid |
9.45 | 17936198 16804969 17991707 16474422 11698051 16782535 18200517 16867261 18023891 |
MESH:D003093 |
Colitis, Ulcerative |
|
Trinitrobenzenesulfonic Acid |
3.39 | 17276891 |
MESH:D003103 |
Coloboma |
|
Curcumin |
4.41 | 18809619 |
MESH:D003110 |
Colonic Neoplasms |
|
Curcumin |
5.91 | 19359593 16340194 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
5.91 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
rofecoxib |
5.91 | 12902858 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.93 | 14669216 17141729 |
MESH:D016510 |
Corneal Neovascularization |
|
Curcumin |
4.75 | 18497527 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
2.57 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.57 | 10048152 15322242 20055451 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
3.26 | 12438553 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.36 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
4.17 | 17446233 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Curcumin |
7.01 | 18403477 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
7.01 | 12642470 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
7.01 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Curcumin |
3.88 | 18204486 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.55 | 7237001 |
MESH:D004244 |
Dizziness |
|
Astemizole |
6.31 | 3105558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
3.58 | 2869522 16177239 6884620 7440962 7179309 15998439 7120509 15968718 3732212 4309450 10092053 17522070 16227642 11566570 10915739 6623471 3786805 19085960 21278145 9327722 19336974 15027814 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.58 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.65 | 11462148 |
MESH:D004381 |
Duodenal Ulcer |
|
Curcumin |
3.90 | 17351913 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
4.31 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
15.33 | 19703484 |
MESH:D004487 |
Edema |
|
pirinixic acid |
15.33 | 12083418 |
MESH:D004487 |
Edema |
|
rosiglitazone |
15.33 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
15.33 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.75 | 15322242 18230668 16714409 |
MESH:D004715 |
Endometriosis |
|
rofecoxib |
8.88 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.88 | 9294722 10568697 |
MESH:D004802 |
Eosinophilia |
|
Astemizole |
4.65 | 1355641 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
1.97 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.90 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
17.69 | 15959796 61145 16239168 16045604 19224547 17595544 12631006 12795759 |
MESH:D005234 |
Fatty Liver |
|
Curcumin |
17.69 | 19297423 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
17.69 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
17.69 | 19196556 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.31 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
19.97 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Curcumin |
19.97 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
19.97 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Trinitrobenzenesulfonic Acid |
19.97 | 17994277 |
MESH:D005499 |
Folliculitis |
|
Astemizole |
5.77 | 1671328 |
MESH:D005770 |
Gastrointestinal Neoplasms |
|
Curcumin |
4.54 | 18462866 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.53 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Curcumin |
3.38 | 17596214 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.44 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Curcumin |
3.55 | 18462866 18829502 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.18 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.18 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Mitoxantrone |
4.05 | 16019553 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.44 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.20 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.45 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.76 | 19176532 19772884 16221962 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.76 | 12621046 15340226 16120746 |
MESH:D015417 |
Hereditary Sensory and Motor Neuropathy |
|
Curcumin |
4.89 | 17701891 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
3.02 | 7520565 |
MESH:D006561 |
Herpes Simplex |
|
Etoposide |
4.41 | 10809021 |
MESH:D006689 |
Hodgkin Disease |
|
Etoposide |
7.22 | 17606976 15147373 16135485 16200630 18180244 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
7.22 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.89 | 18606429 15340226 8697196 16959395 16354765 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
3.80 | 12083418 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.38 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Curcumin |
3.91 | 18704882 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.05 | 20558911 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
8.39 | 17042910 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
8.39 | 8949925 12717712 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.39 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.94 | 15338365 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.42 | 12791704 18502941 |
MESH:D007077 |
Ileal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.29 | 18306037 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.89 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Curcumin |
11.38 | 18403477 16956363 17151092 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
11.38 | 8960868 11099482 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
11.38 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
11.38 | 12200463 12878042 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Curcumin |
6.49 | 18596194 18200517 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Trinitrobenzenesulfonic Acid |
6.49 | 18200517 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.18 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
7.18 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
rofecoxib |
9.95 | 15831440 |
MESH:D007410 |
Intestinal Diseases |
|
Trinitrobenzenesulfonic Acid |
9.95 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
Curcumin |
4.09 | 10783313 |
MESH:D007417 |
Intestinal Polyps |
|
rofecoxib |
5.22 | 11245490 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.20 | 16580747 |
MESH:D007579 |
Jejunal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.29 | 18306037 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
2.72 | 20008137 |
MESH:D007889 |
Leiomyoma |
|
Curcumin |
4.43 | 18555241 |
MESH:D007938 |
Leukemia |
|
Curcumin |
3.17 | 18462866 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Mitoxantrone |
3.72 | 18172266 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Curcumin |
4.07 | 16106398 |
MESH:D015458 |
Leukemia, T-Cell |
|
Curcumin |
4.61 | 16106398 |
MESH:D017513 |
Lichen Nitidus |
|
Astemizole |
6.31 | 2563723 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.73 | 16239168 17334410 11408273 21278145 17174718 11903743 16943688 16221502 17157831 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
10.64 | 12632512 18472094 15123356 16015684 17805973 15893842 18156304 18317297 15338365 14512876 16027843 15370692 17721639 11481614 13678700 18395914 12632514 12666154 16248980 17823541 15673190 18705752 18210741 17900296 15996030 16116963 18187930 18420326 12445421 17557913 12667390 18277467 16192424 14716833 18205269 16033810 17525996 14716496 12958196 17565644 17640975 18472332 18418968 17922224 18339082 16011737 15730626 17976157 15876570 14620537 12586293 18006644 15362042 17631135 17766677 18263696 10355542 15959796 18429990 15057751 12741479 15818738 18279442 17761835 17708605 14748882 17869086 18395095 15925388 17481882 12649538 14724832 18054572 16638106 17698563 18166357 18481824 12546737 17714472 16097048 18251166 17944888 18376398 16136751 12898905 18412020 12389079 15052691 15650968 15931870 12609069 20821823 12445418 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Curcumin |
10.64 | 18006644 18705752 17355460 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
10.64 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
10.64 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rofecoxib |
10.64 | 17565644 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
10.64 | 17347453 15980055 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
10.64 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
4.13 | 15830285 16246199 16964402 17285989 15720792 |
MESH:D008107 |
Liver Diseases |
|
Curcumin |
4.13 | 16956363 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.01 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.56 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
17.24 | 9163691 15890375 2125692 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
17.24 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
17.24 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
17.24 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
17.24 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
17.24 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
9.26 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
9.26 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.26 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Astemizole |
4.48 | 18472280 11989578 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.07 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
8.31 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
8.31 | 18816296 17053015 18569708 18520028 20869020 20464547 20064080 6695378 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Curcumin |
8.31 | 16243823 19359593 18462866 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
8.31 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
8.31 | 17306315 19931552 17077188 15276417 16712894 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
8.31 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Curcumin |
7.60 | 18462866 |
MESH:D008223 |
Lymphoma |
|
Etoposide |
7.60 | 12556972 12854902 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Curcumin |
4.54 | 16173963 |
MESH:D008288 |
Malaria |
|
Astemizole |
4.64 | 16816845 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Corticosterone |
6.32 | 12807724 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
6.32 | 16827153 |
MESH:D008545 |
Melanoma |
|
Curcumin |
3.43 | 17885582 18462866 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.43 | 16487513 19082730 |
MESH:D008569 |
Memory Disorders |
|
Curcumin |
4.01 | 17263510 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
4.25 | 17261469 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.07 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
Curcumin |
7.23 | 19372569 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
7.23 | 15867202 16118317 15744524 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
Curcumin |
4.77 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.36 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
3.46 | 9809623 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.08 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.90 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.83 | 16411023 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Curcumin |
4.22 | 18495463 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
11.28 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Mitoxantrone |
11.28 | 16640825 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
11.28 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
11.28 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.52 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Curcumin |
4.38 | 12497104 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.07 | 14600291 |
MESH:D009423 |
Nervous System Neoplasms |
|
Curcumin |
5.48 | 18462866 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.05 | 12854658 |
MESH:D009447 |
Neuroblastoma |
|
Topotecan |
3.77 | 15176712 |
MESH:D009759 |
Nystagmus, Pathologic |
|
Astemizole |
6.31 | 6135121 |
MESH:D009765 |
Obesity |
|
Curcumin |
4.48 | 19297423 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.48 | 20558911 |
MESH:D010003 |
Osteoarthritis |
|
rofecoxib |
4.29 | 16690336 |
MESH:D010024 |
Osteoporosis |
|
Curcumin |
3.38 | 18719352 |
MESH:D010051 |
Ovarian Neoplasms |
|
Curcumin |
4.90 | 18462866 19020741 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.90 | 17306315 15276417 |
MESH:D010149 |
Pain, Postoperative |
|
rofecoxib |
5.24 | 18165598 16678543 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Curcumin |
5.56 | 19401701 19196508 17440100 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Etoposide |
5.56 | 19003803 |
MESH:D010195 |
Pancreatitis |
|
Trinitrobenzenesulfonic Acid |
4.06 | 17698068 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.10 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.41 | 18163543 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.46 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.04 | 11222880 11118676 11399792 11896295 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.92 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Curcumin |
1.92 | 18226269 10851300 15129424 12497104 18156803 18769126 11398177 |
MESH:D011471 |
Prostatic Neoplasms |
|
Etoposide |
1.92 | 17172428 |
MESH:D011471 |
Prostatic Neoplasms |
|
Hyaluronic Acid |
1.92 | 16864594 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.92 | 16039940 |
MESH:D011656 |
Pulmonary Emphysema |
|
Curcumin |
4.39 | 19168576 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.31 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Curcumin |
8.83 | 18379247 10666014 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
8.83 | 18379247 11700416 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.69 | 18990726 |
MESH:D012221 |
Rhinitis, Allergic, Perennial |
|
Astemizole |
5.28 | 10822083 |
MESH:D012468 |
Salivary Gland Neoplasms |
marker/mechanism |
|
| 16762588 |
MESH:D012509 |
Sarcoma |
|
Curcumin |
3.98 | 18462866 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Etoposide |
4.56 | 14601052 |
MESH:D018805 |
Sepsis |
|
Curcumin |
3.95 | 18389075 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.55 | 7327846 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
12.97 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
12.97 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
12.97 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
12.97 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.68 | 12854658 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
4.17 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.55 | 20155912 2093021 |
MESH:D013276 |
Stomach Ulcer |
|
Curcumin |
7.08 | 16631530 19188055 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
7.08 | 15138204 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.75 | 12697716 |
MESH:D016171 |
Torsades de Pointes |
|
Astemizole |
5.05 | 9583453 8256756 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.03 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Curcumin |
8.03 | 18593936 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
8.03 | 16712894 16452187 11723127 17306315 |
MESH:D014565 |
Urogenital Neoplasms |
|
Curcumin |
5.11 | 18462866 |
MESH:D014581 |
Urticaria |
|
Astemizole |
4.65 | 2565098 2147912 3097109 1683191 2885854 1976298 2568013 2568189 3080510 2859714 3134034 2883202 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.63 | 11813266 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
4.67 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.27 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.44 | 12125929 |
MESH:D014717 |
Vertigo |
|
Astemizole |
6.31 | 3105558 |
OMIM:143200 |
WAGNER SYNDROME 1 |
marker/mechanism |
|
| |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.10 | 15886252 |